Jefferies, BofA, Leerink, Guggenheim, Truist and LifeSci Capital acted as joint book running managers for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRUS:
- Merus’s Promising Clinical Developments and Market Potential Justify Buy Rating
- Closing Bell Movers: Guidewire up 11% after Q3 beat, guidance raise
- Merus announces common shares offering, no amount given
- Merus’s Strong Clinical Data and Financial Stability Justify Buy Rating
- Merus Announces Promising Phase 2 Trial Results